Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Retroviral transfer of the multidrug resistance-1 gene into lineage-committed and primitive hemopoietic cells. [electronic resource] by
- Fruehauf, S
- Boesen, J J
- Breems, D A
- Höft, R
- Hundsdörfer, P
- Zeller, W J
- Löwenberg, B
- Ploemacher, R E
- Haas, R
- Valerio, D
Producer: 19961009
In:
Stem cells (Dayton, Ohio) vol. 13 Suppl 3
Availability: No items available.
|
|
12.
|
Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. [electronic resource] by
- Fruehauf, S
- Breems, D A
- Knaän-Shanzer, S
- Brouwer, K B
- Haas, R
- Löwenberg, B
- Nooter, K
- Ploemacher, R E
- Valerio, D
- Boesen, J J
Producer: 19961119
In:
Human gene therapy vol. 7
Availability: No items available.
|
|
13.
|
|
|
14.
|
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells. [electronic resource] by
- Terpstra, W
- Rozemuller, H
- Breems, D A
- Rombouts, E J
- Prins, A
- FitzGerald, D J
- Kreitman, R J
- Wielenga, J J
- Ploemacher, R E
- Löwenberg, B
- Hagenbeek, A
- Martens, A C
Producer: 19971118
In:
Blood vol. 90
Availability: No items available.
|
|
15.
|
|
|
16.
|
Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. [electronic resource] by
- Daenen, S
- van der Holt, B
- Dekker, A W
- Willemze, R
- Rijneveld, A W
- Biemond, B J
- Muus, P
- van de Loosdrecht, A A
- Schouten, H C
- van Marwijk Kooy, M
- Breems, D A
- Demuynck, H
- Maertens, J
- Wijermans, P W
- Wittebol, S
- de Klerk, E W
- Cornelissen, J J
Producer: 20121009
In:
Leukemia vol. 26
Availability: No items available.
|
|
17.
|
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. [electronic resource] by
- Cornelissen, J J
- Versluis, J
- Passweg, J R
- van Putten, W L J
- Manz, M G
- Maertens, J
- Beverloo, H B
- Valk, P J M
- van Marwijk Kooy, M
- Wijermans, P W
- Schaafsma, M R
- Biemond, B J
- Vekemans, M-C
- Breems, D A
- Verdonck, L F
- Fey, M F
- Jongen-Lavrencic, M
- Janssen, J J W M
- Huls, G
- Kuball, J
- Pabst, T
- Graux, C
- Schouten, H C
- Gratwohl, A
- Vellenga, E
- Ossenkoppele, G
- Löwenberg, B
Producer: 20150803
In:
Leukemia vol. 29
Availability: No items available.
|
|
18.
|
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS. [electronic resource] by
- Ossenkoppele, G J
- Breems, D A
- Stuessi, G
- van Norden, Y
- Bargetzi, M
- Biemond, B J
- A von dem Borne, P
- Chalandon, Y
- Cloos, J
- Deeren, D
- Fehr, M
- Gjertsen, B
- Graux, C
- Huls, G
- Janssen, J J J W
- Jaspers, A
- Jongen-Lavrencic, M
- de Jongh, E
- Klein, S K
- van der Klift, M
- van Marwijk Kooy, M
- Maertens, J
- Michaux, L
- van der Poel, M W M
- van Rhenen, A
- Tick, L
- Valk, P
- Vekemans, M C
- van der Velden, W J F M
- de Weerdt, O
- Pabst, T
- Manz, M
- Löwenberg, B
Producer: 20201027
In:
Leukemia vol. 34
Availability: No items available.
|